Vyome Holdings, Inc. (NasdaqCM: HIND)
Health Care · Pharmaceuticals · US
$2.09
+9.42% today · -58.3% 1Y
Vyome Holdings, Inc. (NasdaqCM: HIND) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $14.67M and employs 18 people.
Over the last twelve months the share price has lost 58.3%, trading between 1.75 and 6.56.
Tweenvest scores Vyome Holdings, Inc. across four factors: quality 45/100, value 39/100. Its strongest factor is quality.
HIND price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $14.67M
- Revenue (TTM)
- $129.72K
- P/E
- —
- EPS
- -1.61
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $6.56
- 52-week low
- $1.75
- Avg volume (3M)
- —
- Shares outstanding
- 7.02M
- Employees
- 18
- Next earnings
- —
About Vyome Holdings, Inc.
Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.
- ISIN
- US92943X1046
- Listed since
- Oct 6, 2016
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PeterLabs Holdings BerhadKLSE: PLABS | $15.16M | RM0.23 | +2.27% |
| Par Drugs and Chemicals LimitedNSEI: PAR | $14.89M | Rs117.10 | -5.53% |
| 1CM Inc.CNSX: EPIC | $14.85M | CA$0.18 | — |
| Thalia Therapeutics PlcAIM: THAT | $14.69M | £0.01 | -0.80% |
| Ambee Pharmaceuticals PLCDSE: AMBEEPHA | $14.65M | Tk752.00 | +1.43% |
| Godavari Drugs LimitedBSE: 530317 | $14.65M | Rs140.00 | +18.59% |
| Union Korea Pharm Co., Ltd.KOSDAQ: A080720 | $14.59M | ₩— | — |
| Biofrontera Inc.NasdaqCM: BFRI | $14.41M | $0.93 | -4.64% |
Figures last refreshed Oct 11, 2026.